| Dr Alan Marvin Keller, MD | |
|
12697 E 51st St, Tulsa, OK 74146-6236 | |
| (918) 505-3200 | |
| (918) 505-3253 |
| Full Name | Dr Alan Marvin Keller |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 51 Years |
| Location | 12697 E 51st St, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386696011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 11735 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Cancer Specialists And Research Institute, Llc | 0042513558 | 50 |
News Archive
Non-specialist health workers are beneficial in providing treatment for people with mental, neurological and substance-abuse (MNS) problems in developing countries - where there is often a lack of mental health professionals - according to a new Cochrane review.
New research from scientists at UT Southwestern Medical Center and the Dallas Veterans Affairs Medical Center underscores the importance of preventing recurring acid reflux while also uncovering tantalizing clues on how typical acid reflux can turn potentially cancerous.
A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole, help alleviate depression, fatigue, pain, anxiety, insomnia and gastrointestinal problems in Chinese cancer patients.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Uganda on Saturday launched a three-day polio and measles immunization campaign, Possy Mugyenyi, the country's immunization manager, said, UGPulse.com reports (Nyanzi, UGPulse.com, 6/5). More than 6 million children are being targeted, IRIN reports (IRIN, 6/5).
› Verified 6 days ago
| Entity Name | Oklahoma Cancer Specialists And Research Institute, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104291236 PECOS PAC ID: 0042513558 Enrollment ID: O20160115001766 |
News Archive
Non-specialist health workers are beneficial in providing treatment for people with mental, neurological and substance-abuse (MNS) problems in developing countries - where there is often a lack of mental health professionals - according to a new Cochrane review.
New research from scientists at UT Southwestern Medical Center and the Dallas Veterans Affairs Medical Center underscores the importance of preventing recurring acid reflux while also uncovering tantalizing clues on how typical acid reflux can turn potentially cancerous.
A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole, help alleviate depression, fatigue, pain, anxiety, insomnia and gastrointestinal problems in Chinese cancer patients.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Uganda on Saturday launched a three-day polio and measles immunization campaign, Possy Mugyenyi, the country's immunization manager, said, UGPulse.com reports (Nyanzi, UGPulse.com, 6/5). More than 6 million children are being targeted, IRIN reports (IRIN, 6/5).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Marvin Keller, MD 12697 E 51st St, Tulsa, OK 74146-6236 Ph: (918) 505-3200 | Dr Alan Marvin Keller, MD 12697 E 51st St, Tulsa, OK 74146-6236 Ph: (918) 505-3200 |
News Archive
Non-specialist health workers are beneficial in providing treatment for people with mental, neurological and substance-abuse (MNS) problems in developing countries - where there is often a lack of mental health professionals - according to a new Cochrane review.
New research from scientists at UT Southwestern Medical Center and the Dallas Veterans Affairs Medical Center underscores the importance of preventing recurring acid reflux while also uncovering tantalizing clues on how typical acid reflux can turn potentially cancerous.
A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole, help alleviate depression, fatigue, pain, anxiety, insomnia and gastrointestinal problems in Chinese cancer patients.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Uganda on Saturday launched a three-day polio and measles immunization campaign, Possy Mugyenyi, the country's immunization manager, said, UGPulse.com reports (Nyanzi, UGPulse.com, 6/5). More than 6 million children are being targeted, IRIN reports (IRIN, 6/5).
› Verified 6 days ago
Sarah Anne Shaw-dressler, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave Ste 100a, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Julia Margaret Kwon, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1705 E 19th St Ste 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Peter Madden, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-619-4400 | |
Thao Tran, D.O Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4502 E. 41st Street, Tulsa, OK 74135 Phone: 918-619-4400 | |
Robert Peter Aran, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6160 S Yale Ave Ste 100, Tulsa, OK 74136 Phone: 918-497-3300 Fax: 918-497-3365 | |
Robert Dean Okada, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave, Ste 304, Tulsa, OK 74136 Phone: 918-494-5300 Fax: 918-494-5455 | |
Dr. Charles Wade Taylor, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 Fax: 918-505-3253 |